Star Imaging And Path Lab Stock Screener | Share Price & Fundamental Analysis
STARIMAGIN
Healthcare Service Provider
Screen Star Imaging And Path Lab share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹155.00 Cr.
P/B Ratio
1.53
EPS (TTM)
₹11.80
Dividend Yield
-
Debt to Equity
0.81
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹98.00
Total Equity
₹47.00
Star Imaging And Path Lab Share Price History - Stock Screener Chart
Screen STARIMAGIN historical share price movements with interactive charts. Analyze price trends and patterns.
Star Imaging And Path Lab Company Profile - Fundamental Screener
Screen Star Imaging And Path Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for STARIMAGIN shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE0YG001013
Star Imaging And Path Lab Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen STARIMAGIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 98 | 82 | 61 | 58 |
| Current Assets | 67 | 53 | 26 | 32 |
| Fixed Assets | 21 | 22 | 19 | 15 |
| Liabilities | ||||
| Total Liabilities | 98 | 82 | 61 | 58 |
| Current Liabilities | 17 | 18 | 16 | 19 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 47 | 31 | 19 | 18 |
| Share Capital | 14 | 2 | 2 | 2 |
| Reserves & Surplus | 34 | 30 | 17 | 17 |
Screen STARIMAGIN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
| Revenue | 0 | 84 | 80 | 59 | 69 |
| Expenses | 0 | 55 | 56 | 53 | 54 |
| EBITDA | 0 | 29 | 24 | 6 | 15 |
| Operating Profit % | 0.00% | 34.00% | 29.00% | 10.00% | 21.00% |
| Depreciation | 0 | 5 | 5 | 3 | 4 |
| Interest | 0 | 3 | 2 | 2 | 2 |
| Profit Before Tax | 0 | 21 | 16 | 1 | 9 |
| Tax | 0 | 6 | 4 | 0 | 3 |
| Net Profit | 0 | 16 | 13 | 1 | 6 |
| EPS | 0.00 | 11.80 | 82.78 | 3.89 | 41.95 |
Star Imaging And Path Lab Cash Flow Screener - Liquidity Fundamentals
Screen STARIMAGIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | -6 | 18 | 5 | 14 |
| Investing Activities | -4 | -7 | -7 | -4 |
| Financing Activities | 0 | 2 | -5 | -7 |
| Net Cash Flow | -10 | 13 | -7 | 3 |
Screen STARIMAGIN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Aug | 2025-Sept |
|---|---|---|---|
| Promoter Holding | 100.00% | 71.92% | 71.92% |
| FII Holding | 0.00% | 1.18% | 1.37% |
| DII Holding | 0.00% | 11.44% | 9.33% |
| Govt Holding | 0.00% | 0.00% | 0.00% |
| Public Holding | 0.00% | 11.01% | 12.30% |
| Other Holding | 0.00% | 4.46% | 5.08% |
| Shareholder Count | 7 | 7 | 779 |
Star Imaging And Path Lab Dividend Screener - Share Yield Analysis
Screen STARIMAGIN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Star Imaging And Path Lab Index Membership - Market Screener Classification
Screen STARIMAGIN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Star Imaging And Path Lab Market Events Screener - Corporate Actions
Screen STARIMAGIN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -4.33% |
Star Imaging And Path Lab Competitors Screener - Peer Comparison
Screen STARIMAGIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,700 | 46.83 | 2,555 | 11.28% | 492 | 51.43 |
| Vijaya Diagnostic Centre | 10,881 | 70.34 | 700 | 23.06% | 144 | 61.34 |
| Metropolis Healthcare | 10,019 | 61.96 | 1,346 | 10.64% | 146 | 53.04 |
| Thyrocare Technologies | 7,309 | 56.28 | 702 | 20.80% | 91 | 53.15 |
| Nephrocare Health Services | 4,760 | 68.04 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,379 | 28.37 | 743 | 16.70% | 78 | 46.09 |
| Suraksha Diagnostic | 1,441 | 45.66 | 256 | 15.11% | 31 | 45.86 |
| One Global Service Provider | 1,237 | 28.65 | 148 | 134.60% | 19 | 58.56 |
| 3B BlackBio DX | 1,214 | 24.67 | 112 | 28.72% | 48 | 56.43 |
| Sastasundar Ventures | 1,004 | -103.51 | 1,171 | -18.47% | -134 | 60.55 |
Star Imaging And Path Lab Company Announcements - News Screener
Screen STARIMAGIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Empanelment With WDRA Government Of India | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-13 | Unaudited (Standalone And Consolidated) Financial Results Of The Company For Half Year Ended 30Th September 2025 | View |
| 2025-11-13 | Board Meeting Outcome for Unaudited Financial Result (Standalone And Consolidated) For Half Year Ended 30Th September 2025 | View |
| 2025-11-12 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-11 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-04 | Board Meeting Intimation for To Consider And Approve Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Half Year Ended September 30 2025 | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-15 | Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Monday 15 September 2025 | View |
| 2025-09-04 | Intimation For Change Of Corporate Identification Number (CIN) And Listing Status Of Star Imaging And Path Lab Limited | View |
| 2025-08-18 | Listing of Equity Shares of Star Imaging And Path Lab Ltd | - |